Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
OBS PAKISTAN (PRIVATE) LIMITED
🇵🇰
Pakistan
Country
🇵🇰
Pakistan
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Noroxin Efficacy and Safety Trial
Phase 4
Conditions
Urinary Tract Infections
Interventions
Drug: Norfloxacin 400 MG
Subscribe
First Posted Date
2018-04-24
Last Posted Date
2018-04-24
Lead Sponsor
OBS Pakistan
Target Recruit Count
1000
Registration Number
NCT03506256
Subscribe
Perception and Knowledge About Menopause Among Pakistani Woman
Completed
Conditions
Menopause
Subscribe
First Posted Date
2018-04-24
Last Posted Date
2018-04-24
Lead Sponsor
OBS Pakistan
Target Recruit Count
910
Registration Number
NCT03506269
Locations
🇵🇰
Dr. Faizan Shaukat, Karachi, Sindh, Pakistan
Subscribe
Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)
Phase 4
Conditions
Chronic Stable Angina
Interventions
Drug: Ranolazine
Subscribe
First Posted Date
2018-04-03
Last Posted Date
2018-04-03
Lead Sponsor
OBS Pakistan
Target Recruit Count
2000
Registration Number
NCT03486561
Subscribe
Prevalence of Hyperuricemia in Pakistan
Conditions
Hyperuricemia
Subscribe
First Posted Date
2018-03-22
Last Posted Date
2018-03-22
Lead Sponsor
OBS Pakistan
Target Recruit Count
1000
Registration Number
NCT03473444
Locations
🇵🇰
Dr. Abid Naeem, Mirpur, AJK, Pakistan
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy